2026 Q2 Portfolio Activity
In 2026 Q2, Bellevue Group AG maintained a portfolio of 172 distinct positions. The most significant new addition was CG ONCOLOGY INC, now representing 0.74% of the total fund value. They heavily accumulated shares in AMGEN INC, increasing the position by 188.3%. The fund also reduced its exposure to REGENERON PHARMACEUTICALS by 43.6%.
Position History
hover any row below to update
Loading…
Total Positions
172
Quarter
2026 Q2
Top Holding
AMGN (6.5%)
Top 10 Concentration
42.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 172
Bellevue Group AG Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AMGN
AMGEN INC
|
Healthcare | 6.49% | 2.47% |
#1
13
Prev: #14
|
7.6 |
—
|
556,192 | 188.3% |
P
S
|
851,550 | $308,363,286 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 6.05% | 7.25% |
#2
1
Prev: #1
|
4.4 |
—
|
-103,274 | -15.1% |
P
S
|
578,634 | $287,424,867 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARGX
ARGENX SE
|
Healthcare | 5.88% | 5.44% |
#3
1
Prev: #2
|
3.9 |
—
|
-12,000 | -3.8% |
P
S
|
301,000 | $279,258,770 | 2018 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GILD
GILEAD SCIENCES...
|
Healthcare | 5.74% | 3.88% |
#4
1
Prev: #5
|
5.8 |
—
|
988,893 | 84.5% |
P
S
|
2,158,772 | $272,739,254 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 4.13% | 3.57% |
#5
1
Prev: #6
|
2.2 |
—
|
-496,442 | -32.1% |
P
S
|
1,048,014 | $196,272,062 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 3.32% | 0.59% |
#6
38
Prev: #44
|
4.3 |
—
|
1,150,182 | 226.9% |
P
S
|
1,657,190 | $157,714,772 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSM
INSMED INC
|
Healthcare | 3.13% | 0.04% |
#7
76
Prev: #83
|
4.3 |
—
|
1,383,384 | 13787.0% |
P
S
|
1,393,418 | $148,566,227 | 2018 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 2.83% | 4.19% |
#8
4
Prev: #4
|
1.1 |
—
|
-1,135,026 | -31.7% |
P
S
|
2,449,547 | $134,725,085 | 2019 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NUVL
NUVALENT INC
|
Healthcare | 2.74% | 2.57% |
#9
4
Prev: #13
|
2.1 |
—
|
no change | no change |
P
S
|
1,053,268 | $130,078,598 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 2.60% | 3.13% |
#10
1
Prev: #9
|
1.5 |
—
|
5,765 | 0.1% |
P
S
|
6,731,909 | $123,665,169 | 2022 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 2.44% | 1.85% |
#11
9
Prev: #20
|
1.0 |
—
|
-1,609,272 | -20.6% |
P
S
|
6,185,970 | $115,739,499 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 2.41% | 1.65% |
#12
10
Prev: #22
|
4.0 |
—
|
781,238 | 65.6% |
P
S
|
1,971,935 | $114,628,582 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 2.15% | 0.03% |
#13
74
Prev: #87
|
3.9 |
—
|
186,438 | 8976.3% |
P
S
|
188,515 | $102,143,083 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 2.13% | 3.14% |
#14
6
Prev: #8
|
1.4 |
—
|
-31,845 | -11.1% |
P
S
|
254,809 | $101,332,443 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 2.06% | 5.12% |
#15
12
Prev: #3
|
0.8 |
—
|
-121,383 | -43.6% |
P
S
|
157,291 | $98,077,230 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 2.06% | 2.84% |
#16
5
Prev: #11
|
0.8 |
—
|
-660,000 | -20.1% |
P
S
|
2,620,000 | $98,040,400 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 1.86% | 0.04% |
#17
62
Prev: #79
|
3.7 |
—
|
1,164,129 | 4587.3% |
P
S
|
1,189,506 | $88,594,406 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 1.86% | 2.01% |
#18
1
Prev: #17
|
1.2 |
—
|
-8,558 | -0.3% |
P
S
|
2,788,245 | $88,526,779 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABT
ABBOTT LABORATO...
|
Healthcare | 1.81% | 2.81% |
#19
7
Prev: #12
|
1.2 |
—
|
-204,520 | -17.8% |
P
S
|
947,115 | $85,941,215 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SYK
STRYKER CORPORA...
|
Healthcare | 1.78% | 1.70% |
#20
1
Prev: #21
|
3.2 |
—
|
51,224 | 23.6% |
P
S
|
268,461 | $84,522,261 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MDT
MEDTRONIC PLC
|
Healthcare | 1.64% | 1.97% |
#21
3
Prev: #18
|
1.2 |
—
|
36,904 | 3.9% |
P
S
|
994,233 | $77,778,848 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 1.62% | 3.25% |
#22
15
Prev: #7
|
0.6 |
—
|
-846,407 | -46.5% |
P
S
|
972,258 | $77,090,336 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 1.59% | 2.17% |
#23
7
Prev: #16
|
0.6 |
—
|
-830,867 | -35.8% |
P
S
|
1,490,000 | $75,617,500 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 1.54% | 1.64% |
#24
1
Prev: #23
|
1.1 |
—
|
37 | 0.0% |
P
S
|
1,710,808 | $73,410,771 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JBIO
JADE BIOSCIENCE...
|
Healthcare | 1.43% | 1.17% |
#25
5
Prev: #30
|
1.1 |
—
|
-443,506 | -12.7% |
P
S
|
3,057,996 | $67,948,671 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 1.41% | 1.60% |
#26
2
Prev: #24
|
1.1 |
—
|
-100,217 | -11.9% |
P
S
|
739,234 | $66,871,108 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 1.39% | 1.19% |
#27
1
Prev: #28
|
1.1 |
—
|
-397,225 | -16.7% |
P
S
|
1,982,775 | $66,204,857 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 1.30% | 0.95% |
#28
4
Prev: #32
|
1.0 |
—
|
924 | 0.6% |
P
S
|
149,127 | $61,981,655 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DXCM
DEXCOM INC
|
Healthcare | 1.17% | 1.18% |
#29
Prev: #29
|
1.0 |
—
|
33,723 | 4.3% |
P
S
|
822,489 | $55,394,634 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 0.94% | 0.91% |
#30
4
Prev: #34
|
1.4 |
—
|
no change | no change |
P
S
|
1,200,000 | $44,652,000 | 2022 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
AVALYN PHARMACE...
|
|
Unknown | 0.94% | — |
#31
Prev: #—
|
3.9 |
—
|
1,350,000 | — |
NEW
|
1,350,000 | $44,442,000 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
GLTO
DAMORA THERAPEU...
|
Healthcare | 0.89% | 1.42% |
#32
7
Prev: #25
|
0.4 |
—
|
-679,154 | -29.6% |
P
S
|
1,618,846 | $42,106,184 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 0.86% | 0.70% |
#33
7
Prev: #40
|
2.8 |
—
|
100,686 | 21.9% |
P
S
|
560,000 | $40,958,400 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 0.84% | 0.75% |
#34
3
Prev: #37
|
2.8 |
—
|
15,404 | 23.9% |
P
S
|
79,816 | $40,016,550 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 0.80% | 2.19% |
#35
20
Prev: #15
|
0.3 |
—
|
-579,244 | -39.5% |
P
S
|
887,650 | $37,884,902 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 0.75% | 0.74% |
#36
2
Prev: #38
|
0.8 |
—
|
-4,050 | -11.9% |
P
S
|
29,882 | $35,841,367 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 0.74% | — |
#37
Prev: #—
|
3.8 |
—
|
493,596 | — |
NEW
|
493,596 | $35,069,996 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IDXX
IDEXX LABS INC
|
Healthcare | 0.68% | 1.19% |
#38
11
Prev: #27
|
0.3 |
—
|
-27,351 | -30.7% |
P
S
|
61,780 | $32,523,463 | 2018 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RMD
RESMED INC
|
Healthcare | 0.61% | 0.85% |
#39
4
Prev: #35
|
0.7 |
—
|
-11,151 | -7.0% |
P
S
|
148,195 | $28,880,242 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 0.61% | 2.96% |
#40
30
Prev: #10
|
0.2 |
—
|
-404,255 | -83.9% |
P
S
|
77,530 | $28,815,575 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 0.61% | 0.49% |
#41
8
Prev: #49
|
0.7 |
—
|
-60,000 | -4.8% |
P
S
|
1,190,000 | $28,798,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DHR
DANAHER CORP DE...
|
Healthcare | 0.58% | 0.91% |
#42
9
Prev: #33
|
0.2 |
—
|
-58,320 | -28.8% |
P
S
|
143,844 | $27,399,405 | 2016 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JNJ
JOHNSON & JOHNS...
|
Healthcare | 0.55% | 0.69% |
#43
2
Prev: #41
|
0.7 |
—
|
-15,822 | -13.3% |
P
S
|
103,280 | $26,230,022 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
SEAPORT THERAPE...
|
|
Unknown | 0.50% | — |
#44
Prev: #—
|
3.7 |
—
|
1,100,000 | — |
NEW
|
1,100,000 | $23,892,000 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 0.50% | — |
#45
Prev: #—
|
3.7 |
—
|
155,000 | — |
NEW
|
155,000 | $23,687,100 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALGN
ALIGN TECHNOLOG...
|
Healthcare | 0.50% | 0.57% |
#46
Prev: #46
|
1.2 |
—
|
no change | no change |
P
S
|
139,680 | $23,558,429 | 2017 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ANNX
ANNEXON INC
|
Healthcare | 0.49% | 0.68% |
#47
5
Prev: #42
|
0.2 |
—
|
-1,057,274 | -20.5% |
P
S
|
4,100,016 | $23,411,091 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HUM
HUMANA INC
|
Healthcare | 0.49% | 0.27% |
#48
12
Prev: #60
|
0.7 |
—
|
-6,100 | -9.5% |
P
S
|
58,398 | $23,196,854 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ELV
ELEVANCE HEALTH...
|
Healthcare | 0.46% | 0.37% |
#49
7
Prev: #56
|
2.2 |
—
|
3,931 | 7.5% |
P
S
|
56,449 | $21,830,522 | 2016 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 0.46% | 1.19% |
#50
24
Prev: #26
|
0.2 |
—
|
-1,705,818 | -71.1% |
P
S
|
694,182 | $21,700,129 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 172 holdings